Refractory primary and secondary headache disorders that dramatically responded to combined treatment of ultrasound-guided percutaneous suprazygomatic pterygopalatine ganglion blocks and non-invasive vagus nerve stimulation: a case series.

In 1981, Devoghel achieved an 85.6% success rate in treating patients with treatment-refractory cluster headaches with alcoholization of the pterygopalatine ganglion (PPG) via the percutaneous suprazygomatic approach. Devoghel's study led to the theory that interrupting the parasympathetic pathway by blocking its transduction at the PPG could prevent or treat symptoms related to primary headache disorders (PHDs). Furthermore, non-invasive vagus nerve stimulation (nVNS) has proven to treat PHDs and has been approved by national regulatory bodies to treat, among others, cluster headaches and migraines.In this case series, nine desperate patients who presented with 11 longstanding treatment-refractory primary headache disorders and epidural blood patch-resistant postdural puncture headache (PDPH) received ultrasound-guided percutaneous suprazygomatic pterygopalatine ganglion blocks (PPGB), and seven also received nVNS. The patients were randomly selected and were not part of a research study. They experienced dramatic, immediate, satisfactory, and apparently lasting symptom resolution (at the time of the writing of this report). The report provides the case descriptions, briefly reviews the trigeminovascular and neurogenic inflammatory theories of the pathophysiology, outlines aspects of these PPGB and nVNS interventions, and argues for adopting this treatment regime as a first-line or second-line treatment rather than desperate last-line treatment of PDPH and PHDs.

Urinary stone disease: comparison of standard-dose and low-dose with 4D MDCT tube current modulation.

OBJECTIVE: The purpose of this prospective study was to compare the performance of standard-dose MDCT with that of low-dose MDCT with tube current modulation in patients with renal colic. SUBJECTS AND METHODS: Three hundred patients underwent 6- and 16-MDCT in 150 standard-dose examinations (6-MDCT effective tube current, 95 mAs at 130 kV; 16-MDCT effective tube current, 120 mAs at 120 kV) and 150 low-dose examinations (6-MDCT effective tube current, 51 mAs at 110 kV; 16-MDCT effective tube current, 70 mAs at 120 kV), all performed with 4D tube current modulation. Two experienced radiologists using a clinical workstation and blinded to scan parameters prospectively viewed the images from the 300 examinations. In a second session, one experienced radiologist and two first-year residents using a clinical workstation retrospectively reviewed images from 100 randomly selected standard-dose and 100 randomly selected low-dose examinations. RESULTS: Tube current modulation reduced effective tube current 25-31% in all examinations. Mean effective dose was 1.41-1.58 mSv for low-dose examinations, which reached additional dose reduction of 51.2-64.3% in comparison with standard-dose examinations. Excellent correlation existed between mean tube current and body mass index of the patients. Spearman's correlation coefficient was 0.85-0.88 for all examinations. The sensitivity of low-dose examinations interpreted by two experienced reviewers was 97.3-98.6%; specificity, 93.5%; and accuracy, 95.3%. These findings were comparable with those for standard-dose examinations. Sensitivity, specificity, and accuracy of low-dose examinations of overweight and obese patients reached similar high values: 97-100%, 100%, and 98-100%, respectively. Interobserver agreement for urinary stone detection was excellent between the two reviewers, with kappa values of 0.98 for the low-dose and 0.96 for the standard-dose examinations. An alternative diagnosis was identified in 15% and 16% of cases by two experienced radiologists in the two examinations groups. In the second interpretation session, the residents found an alternative diagnosis in only 10-12% of standard-dose examinations and only 4-5% of low-dose examinations. CONCLUSION: Low-dose MDCT with tube current modulation can be used as standard procedure in evaluation for urolithiasis, even in overweight and obese patients.